1. Home
  2. SNDX vs PDFS Comparison

SNDX vs PDFS Comparison

Compare SNDX & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • PDFS
  • Stock Information
  • Founded
  • SNDX 2005
  • PDFS 1992
  • Country
  • SNDX United States
  • PDFS United States
  • Employees
  • SNDX N/A
  • PDFS N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • PDFS EDP Services
  • Sector
  • SNDX Health Care
  • PDFS Technology
  • Exchange
  • SNDX Nasdaq
  • PDFS Nasdaq
  • Market Cap
  • SNDX 1.2B
  • PDFS 1.1B
  • IPO Year
  • SNDX 2016
  • PDFS N/A
  • Fundamental
  • Price
  • SNDX $14.53
  • PDFS $27.46
  • Analyst Decision
  • SNDX Strong Buy
  • PDFS Strong Buy
  • Analyst Count
  • SNDX 10
  • PDFS 3
  • Target Price
  • SNDX $36.20
  • PDFS $42.33
  • AVG Volume (30 Days)
  • SNDX 2.1M
  • PDFS 210.3K
  • Earning Date
  • SNDX 02-25-2025
  • PDFS 02-13-2025
  • Dividend Yield
  • SNDX N/A
  • PDFS N/A
  • EPS Growth
  • SNDX N/A
  • PDFS 56.69
  • EPS
  • SNDX N/A
  • PDFS 0.11
  • Revenue
  • SNDX $16,000,000.00
  • PDFS $170,505,000.00
  • Revenue This Year
  • SNDX N/A
  • PDFS $9.87
  • Revenue Next Year
  • SNDX N/A
  • PDFS $19.37
  • P/E Ratio
  • SNDX N/A
  • PDFS $246.64
  • Revenue Growth
  • SNDX N/A
  • PDFS 3.19
  • 52 Week Low
  • SNDX $12.06
  • PDFS $25.61
  • 52 Week High
  • SNDX $25.34
  • PDFS $39.70
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 57.25
  • PDFS 45.16
  • Support Level
  • SNDX $13.61
  • PDFS $25.61
  • Resistance Level
  • SNDX $14.62
  • PDFS $27.93
  • Average True Range (ATR)
  • SNDX 0.62
  • PDFS 0.89
  • MACD
  • SNDX 0.15
  • PDFS 0.04
  • Stochastic Oscillator
  • SNDX 91.20
  • PDFS 43.59

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

Share on Social Networks: